- Zensar reported Q4FY13 numbers below our expectations
- Revenues declined 3.2% QoQ on the back lower product sales.
- EBIDTA margins remained flat QoQ at 13.1% due to some setup costs for large deals which are to begin in Q1FY14.
- Company has given a guidance of 4-6% QoQ growth for Q1FY14
- At CMP, the stock is trading at a 4.6x its expected FY14E earnings. We will come out with detailed note and view post scheduled concall today.
